7HD Stock Overview
Engages in the wholesale distribution of pharmaceuticals in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 7HD from our risk checks.
NEUCA S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł176.60 |
| 52 Week High | zł222.00 |
| 52 Week Low | zł169.40 |
| Beta | 0.42 |
| 11 Month Change | -3.71% |
| 3 Month Change | -10.63% |
| 1 Year Change | 0.23% |
| 33 Year Change | 5.12% |
| 5 Year Change | n/a |
| Change since IPO | 18.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7HD | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.2% | 0.2% | 0.8% |
| 1Y | 0.2% | 13.9% | 8.6% |
Return vs Industry: 7HD underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: 7HD underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| 7HD volatility | |
|---|---|
| 7HD Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7HD has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7HD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 4,633 | Piotr Sucharski | www.neuca.pl |
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors, and patients.
NEUCA S.A. Fundamentals Summary
| 7HD fundamental statistics | |
|---|---|
| Market cap | €810.73m |
| Earnings (TTM) | €37.50m |
| Revenue (TTM) | €2.87b |
21.6x
P/E Ratio0.3x
P/S RatioIs 7HD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7HD income statement (TTM) | |
|---|---|
| Revenue | zł12.34b |
| Cost of Revenue | zł10.92b |
| Gross Profit | zł1.43b |
| Other Expenses | zł1.26b |
| Earnings | zł161.38m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 36.13 |
| Gross Margin | 11.55% |
| Net Profit Margin | 1.31% |
| Debt/Equity Ratio | 49.9% |
How did 7HD perform over the long term?
See historical performance and comparison